home.social

#riskdifference — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #riskdifference, aggregated by home.social.

  1. Press Release: ESCMID: Sanofi’s Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study

    Sanofi Winthrop Industrie ESCMID: Sanofi’s Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head,…
    #France #FR #Europe #EU #Sanofi #Germany #Munich #Nuvaxovid #recipients #riskdifference #studyparticipants #systemicsymptoms #vaccines
    europesays.com/france/21304/